SOPHiA Genetics SA
Open
$4.92
Prev. Close
$4.92
High
$4.92
Low
$4.87
Market Snapshot
$334.21M
-4.1
-1.00
$67.17M
415
SOPHiA GENETICS SA is a healthcare technology company, which engages in the practice of data driven medicine as the standard of care and for life sciences research. The company is headquartered in Rolle, Vaud and currently employs 415 full-time employees. The company went IPO on 2021-07-23. The Company’s key product is SOPHiA DDM, which is a cloud-native software-as-a-service (SaaS) platform. The platform analyses multimodal data, including genomics, radiomics, clinical, biological, and digital pathology data, to generate actionable insights for patients with cancer or rare diseases, bringing the power of data-driven medicine to patients across the globe. Additionally, the Company aids BioPharma partners with artificial-intelligence-powered drug discovery, development, and deployment. The firm has offices in Switzerland, France, and the United States and operates worldwide.
SOPHiA GENETICS SA is a healthcare technology company, which engages in the practice of data driven medicine as the standard of care and for life sciences research. The company is headquartered in Rolle, Vaud and currently employs 415 full-time employees. The company went IPO on 2021-07-23. The Company’s key product is SOPHiA DDM, which is a cloud-native software-as-a-service (SaaS) platform. The platform analyses multimodal data, including genomics, radiomics, clinical, biological, and digital pathology data, to generate actionable insights for patients with cancer or rare diseases, bringing the power of data-driven medicine to patients across the globe. Additionally, the Company aids BioPharma partners with artificial-intelligence-powered drug discovery, development, and deployment. The firm has offices in Switzerland, France, and the United States and operates worldwide.
Recently from Cashu
Couldn't load Cashu news
Something went wrong. Try refreshing the page.